129 related articles for article (PubMed ID: 23330639)
1. Multiparametric homogeneous method for identification of ligand binding to G protein-coupled receptors: receptor-ligand binding and β-arrestin assay.
Kopra K; Kainulainen M; Mikkonen P; Rozwandowicz-Jansen A; Hänninen P; Härmä H
Anal Chem; 2013 Feb; 85(4):2276-81. PubMed ID: 23330639
[TBL] [Abstract][Full Text] [Related]
2. A new simple cell-based homogeneous time-resolved fluorescence QRET technique for receptor-ligand interaction screening.
Härmä H; Rozwandowicz-Jansen A; Martikkala E; Frang H; Hemmilä I; Sahlberg N; Fey V; Perälä M; Hänninen P
J Biomol Screen; 2009 Sep; 14(8):936-43. PubMed ID: 19684287
[TBL] [Abstract][Full Text] [Related]
3. beta-Arrestin recruitment assay for the identification of agonists of the sphingosine 1-phosphate receptor EDG1.
van Der Lee MM; Bras M; van Koppen CJ; Zaman GJ
J Biomol Screen; 2008 Dec; 13(10):986-98. PubMed ID: 19036707
[TBL] [Abstract][Full Text] [Related]
4. Characterizing cannabinoid CB2 receptor ligands using DiscoveRx PathHunter beta-arrestin assay.
McGuinness D; Malikzay A; Visconti R; Lin K; Bayne M; Monsma F; Lunn CA
J Biomol Screen; 2009 Jan; 14(1):49-58. PubMed ID: 19171920
[TBL] [Abstract][Full Text] [Related]
5. Structure-Based Prediction of G-Protein-Coupled Receptor Ligand Function: A β-Adrenoceptor Case Study.
Kooistra AJ; Leurs R; de Esch IJ; de Graaf C
J Chem Inf Model; 2015 May; 55(5):1045-61. PubMed ID: 25848966
[TBL] [Abstract][Full Text] [Related]
6. A homogeneous single-label quenching resonance energy transfer assay for a δ-opioid receptor-ligand using intact cells.
Kopra K; Shweta ; Martikkala E; Hänninen P; Petäjä-Repo U; Härmä H
Analyst; 2013 Sep; 138(17):4907-14. PubMed ID: 23800721
[TBL] [Abstract][Full Text] [Related]
7. Characterization of isoprenaline- and salmeterol-stimulated interactions between beta2-adrenoceptors and beta-arrestin 2 using beta-galactosidase complementation in C2C12 cells.
Carter AA; Hill SJ
J Pharmacol Exp Ther; 2005 Nov; 315(2):839-48. PubMed ID: 16051698
[TBL] [Abstract][Full Text] [Related]
8. Recruitment of β-arrestin 1 and 2 to the β2-adrenoceptor: analysis of 65 ligands.
Littmann T; Göttle M; Reinartz MT; Kälble S; Wainer IW; Ozawa T; Seifert R
J Pharmacol Exp Ther; 2015 Nov; 355(2):183-90. PubMed ID: 26306764
[TBL] [Abstract][Full Text] [Related]
9. Monitoring β-arrestin recruitment via β-lactamase enzyme fragment complementation: purification of peptide E as a low-affinity ligand for mammalian bombesin receptors.
Ikeda Y; Kumagai H; Okazaki H; Fujishiro M; Motozawa Y; Nomura S; Takeda N; Toko H; Takimoto E; Akazawa H; Morita H; Suzuki J; Yamazaki T; Komuro I; Yanagisawa M
PLoS One; 2015; 10(6):e0127445. PubMed ID: 26030739
[TBL] [Abstract][Full Text] [Related]
10. High-throughput analysis of ligand-induced internalization of β2-adrenoceptors using the coiled-coil tag-probe method.
Takeda Y; Yano Y; Matsuzaki K
Anal Chem; 2012 Feb; 84(3):1754-9. PubMed ID: 22243418
[TBL] [Abstract][Full Text] [Related]
11. Lipid G protein-coupled receptor ligand identification using beta-arrestin PathHunter assay.
Yin H; Chu A; Li W; Wang B; Shelton F; Otero F; Nguyen DG; Caldwell JS; Chen YA
J Biol Chem; 2009 May; 284(18):12328-38. PubMed ID: 19286662
[TBL] [Abstract][Full Text] [Related]
12. Binding of purified recombinant beta-arrestin to guanine-nucleotide-binding-protein-coupled receptors.
Söhlemann P; Hekman M; Puzicha M; Buchen C; Lohse MJ
Eur J Biochem; 1995 Sep; 232(2):464-72. PubMed ID: 7556195
[TBL] [Abstract][Full Text] [Related]
13. Screening β-arrestin recruitment for the identification of natural ligands for orphan G-protein-coupled receptors.
Southern C; Cook JM; Neetoo-Isseljee Z; Taylor DL; Kettleborough CA; Merritt A; Bassoni DL; Raab WJ; Quinn E; Wehrman TS; Davenport AP; Brown AJ; Green A; Wigglesworth MJ; Rees S
J Biomol Screen; 2013 Jun; 18(5):599-609. PubMed ID: 23396314
[TBL] [Abstract][Full Text] [Related]
14. Homogeneous GTP binding assay employing QRET technology.
Rozwandowicz-Jansen A; Laurila J; Martikkala E; Frang H; Hemmilä I; Scheinin M; Hänninen P; Härmä H
J Biomol Screen; 2010 Mar; 15(3):261-7. PubMed ID: 20103692
[TBL] [Abstract][Full Text] [Related]
15. beta-arrestin-biased agonism at the beta2-adrenergic receptor.
Drake MT; Violin JD; Whalen EJ; Wisler JW; Shenoy SK; Lefkowitz RJ
J Biol Chem; 2008 Feb; 283(9):5669-76. PubMed ID: 18086673
[TBL] [Abstract][Full Text] [Related]
16. Long Receptor Residence Time of C26 Contributes to Super Agonist Activity at the Human β2 Adrenoceptor.
Rosethorne EM; Bradley ME; Gherbi K; Sykes DA; Sattikar A; Wright JD; Renard E; Trifilieff A; Fairhurst RA; Charlton SJ
Mol Pharmacol; 2016 Apr; 89(4):467-75. PubMed ID: 26772612
[TBL] [Abstract][Full Text] [Related]
17. The cellular distribution of fluorescently labeled arrestins provides a robust, sensitive, and universal assay for screening G protein-coupled receptors.
Oakley RH; Hudson CC; Cruickshank RD; Meyers DM; Payne RE; Rhem SM; Loomis CR
Assay Drug Dev Technol; 2002 Nov; 1(1 Pt 1):21-30. PubMed ID: 15090153
[TBL] [Abstract][Full Text] [Related]
18. The Principles of Ligand Specificity on beta-2-adrenergic receptor.
Chan HC; Filipek S; Yuan S
Sci Rep; 2016 Oct; 6():34736. PubMed ID: 27703221
[TBL] [Abstract][Full Text] [Related]
19. Protocol to Study β-Arrestin Recruitment by CB1 and CB2 Cannabinoid Receptors.
Soethoudt M; van Gils N; van der Stelt M; Heitman LH
Methods Mol Biol; 2016; 1412():103-11. PubMed ID: 27245896
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization of receptor redistribution and beta-arrestin recruitment assays for the cannabinoid receptor 1.
van der Lee MM; Blomenröhr M; van der Doelen AA; Wat JW; Smits N; Hanson BJ; van Koppen CJ; Zaman GJ
J Biomol Screen; 2009 Aug; 14(7):811-23. PubMed ID: 19520790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
